SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-161591
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:32
Documents
13
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d811748d8k.htm   iXBRL 8-K 37327
  Complete submission text file 0001193125-24-161591.txt   163602

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20240614.xsd EX-101.SCH 2856
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20240614_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20240614_pre.xml EX-101.PRE 11711
16 EXTRACTED XBRL INSTANCE DOCUMENT d811748d8k_htm.xml XML 3758
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 241044706
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)